US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
DE69731289D1
(de)
|
1996-03-18 |
2004-11-25 |
Univ Texas |
Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
|
WO1999044630A1
(fr)
|
1998-03-06 |
1999-09-10 |
Chugai Seiyaku Kabushiki Kaisha |
Preparations exemptes de proteines
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US6677136B2
(en)
|
2000-05-03 |
2004-01-13 |
Amgen Inc. |
Glucagon antagonists
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
US7217845B2
(en)
|
2002-11-25 |
2007-05-15 |
Sun Bio, Inc. |
Bifunctional polyethylene glycol derivatives
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
EP1594530A4
(en)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
HYBRID PROTEINS OF ALBUMIN
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20050176108A1
(en)
|
2003-03-13 |
2005-08-11 |
Young-Min Kim |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
WO2005035761A1
(en)
|
2003-10-16 |
2005-04-21 |
Compugen Ltd. |
Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin
|
KR101135244B1
(ko)
|
2007-11-29 |
2012-04-24 |
한미사이언스 주식회사 |
인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
|
US8263084B2
(en)
|
2003-11-13 |
2012-09-11 |
Hanmi Science Co., Ltd |
Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
|
US8846874B2
(en)
|
2003-11-13 |
2014-09-30 |
Hanmi Science Co., Ltd |
IgG Fc fragment for a drug carrier and method for the preparation thereof
|
US20090238838A1
(en)
|
2003-11-13 |
2009-09-24 |
Hanmi Pharm. Ind. Co. Ltd. |
Insulinotropic peptide conjugate using an immunoglobulin fc
|
RU2428431C2
(ru)
|
2004-12-02 |
2011-09-10 |
Домантис Лимитед |
Слитые конструкции лекарственного средства и конъюгаты
|
NZ561361A
(en)
|
2005-02-11 |
2010-02-26 |
Amylin Pharmaceuticals Inc |
GIP hybrid polypeptides with at least two hormonal activities
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물
|
PT1891105E
(pt)
|
2005-06-13 |
2012-06-27 |
Imp Innovations Ltd |
Análogos de oxintomodulina e seus efeitos sobre o comportamento da alimentação
|
GB0511986D0
(en)
|
2005-06-13 |
2005-07-20 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
EP1922336B1
(en)
|
2005-08-11 |
2012-11-21 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
WO2007030375A2
(en)
|
2005-09-08 |
2007-03-15 |
Children's Hospital Medical Center |
Lysosomal acid lipase therapy for nafld and related diseases
|
US7928058B2
(en)
|
2006-02-22 |
2011-04-19 |
Merck Sharp & Dohme Corp. |
Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
|
AU2007258609B2
(en)
|
2006-06-07 |
2013-01-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
KR100880509B1
(ko)
|
2006-10-16 |
2009-01-28 |
한미약품 주식회사 |
재조합 단백질의 대량 생산을 위한 신규한 벡터, 발현세포주 및 이를 이용한 재조합 단백질의 생산 방법
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
GB0624868D0
(en)
|
2006-12-13 |
2007-01-24 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
JP2008169195A
(ja)
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
US20090098130A1
(en)
*
|
2007-01-05 |
2009-04-16 |
Bradshaw Curt W |
Glucagon-like protein-1 receptor (glp-1r) agonist compounds
|
NZ578948A
(en)
|
2007-02-15 |
2012-03-30 |
Univ Indiana Res & Tech Corp |
Glucagon/glp-1 receptor co-agonists
|
EA201070121A1
(ru)
|
2007-07-10 |
2010-06-30 |
Эли Лилли Энд Компани |
Лекарственная форма, содержащая слитый белок glp-1-fc
|
WO2009015763A1
(en)
|
2007-07-27 |
2009-02-05 |
Bayer Cropscience Ag |
Ternary active compound combinations
|
JP5126230B2
(ja)
|
2007-08-07 |
2013-01-23 |
富士通株式会社 |
誤り検出方法
|
WO2009043478A2
(en)
|
2007-09-11 |
2009-04-09 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
JP5771005B2
(ja)
*
|
2007-10-30 |
2015-08-26 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
グルカゴンアンタゴニスト及びglp−1アゴニスト活性を示す化合物
|
EP2214700A4
(en)
|
2007-11-02 |
2012-08-22 |
Janssen Biotech Inc |
HALF-SYNTHETIC GLP-1 PEPTIDE FUSION CONSTRUCTS, METHOD AND USES
|
AU2009210570B2
(en)
|
2008-01-30 |
2014-11-20 |
Indiana University Research And Technology Corporation |
Ester-based insulin prodrugs
|
TWI541023B
(zh)
|
2008-06-17 |
2016-07-11 |
印第安納大學科技研究公司 |
在生理ph緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
|
AR072160A1
(es)
*
|
2008-06-17 |
2010-08-11 |
Univ Indiana Res & Tech Corp |
Co-agonistas del receptor de glucagon/glp-1
|
WO2010013012A2
(en)
|
2008-08-01 |
2010-02-04 |
Lund University Bioscience Ab |
Novel polypeptides and uses thereof
|
JP5765813B2
(ja)
|
2008-09-19 |
2015-08-19 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
治療用ペプチドのポリマーコンジュゲート
|
EP2344200A2
(en)
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modified therapeutics peptides, methods of their preparation and use
|
BRPI0823379A2
(pt)
*
|
2008-12-15 |
2015-07-14 |
Zealand Pharma As |
Análogos de glucagon
|
JP2012512903A
(ja)
|
2008-12-19 |
2012-06-07 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション |
アミド系グルカゴンスーパーファミリーペプチドプロドラッグ
|
PT3178835T
(pt)
|
2009-02-03 |
2019-06-19 |
Amunix Pharmaceuticals Inc |
Polipéptidos recombinantes estendidos e composições que compreendem os mesmos
|
WO2010096052A1
(en)
|
2009-02-19 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin analogs
|
HUE030373T2
(en)
|
2009-03-20 |
2017-05-29 |
Hanmi Science Co Ltd |
A method for producing a site-specific conjugate of a physiologically active polypeptide
|
MX347291B
(es)
|
2009-03-20 |
2017-04-17 |
Amgen Inc |
Inmunoglobulinas portadoras y usos de las mismas.
|
IN2012DN00377A
(zh)
|
2009-06-16 |
2015-08-21 |
Univ Indiana Res & Tech Corp |
|
US9156901B2
(en)
*
|
2009-07-13 |
2015-10-13 |
Ditte Riber |
Acylated glucagon analogues
|
EP2496249B1
(en)
|
2009-11-03 |
2016-03-09 |
Amylin Pharmaceuticals, LLC |
Glp-1 receptor agonist for use in treating obstructive sleep apnea
|
WO2011071957A1
(en)
|
2009-12-07 |
2011-06-16 |
Sea Lane Biotechnologies, Llc |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
AR079345A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
KR20120128129A
(ko)
*
|
2010-01-20 |
2012-11-26 |
질랜드 파마 에이/에스 |
심장 병태의 치료
|
WO2011094337A1
(en)
|
2010-01-27 |
2011-08-04 |
Indiana University Research And Technology Corporation |
Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
|
US20130035285A1
(en)
*
|
2010-03-26 |
2013-02-07 |
Novo Nordisk A/S |
Novel glucagon analogues
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
MX2012013005A
(es)
|
2010-05-13 |
2013-02-26 |
Univ Indiana Res & Tech Corp |
Peptidos de la superfamilia de glucagon que presentan actividad del receptor acoplado a proteinas g.
|
JP2013540102A
(ja)
|
2010-06-24 |
2013-10-31 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション |
アミド結合を介して修飾されたグルカゴンスーパーファミリーのペプチドプロドラッグ
|
KR101337797B1
(ko)
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
KR101382593B1
(ko)
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
JP5282146B2
(ja)
|
2010-09-06 |
2013-09-04 |
パナソニック株式会社 |
表示装置及びその制御方法
|
CN101974077A
(zh)
|
2010-09-15 |
2011-02-16 |
南京瑞年天平医药科技有限公司 |
一种新颖的多肽化合物
|
KR101303388B1
(ko)
|
2010-10-26 |
2013-09-03 |
한미사이언스 주식회사 |
지속형 인터페론 알파 결합체의 액상 제제
|
KR101767570B1
(ko)
|
2010-10-26 |
2017-08-14 |
한미사이언스 주식회사 |
항 비만 펩타이드의 지속형 결합체
|
CN102010473A
(zh)
|
2010-11-10 |
2011-04-13 |
曹鹏 |
重组胃泌酸调节素融合蛋白及其制备和应用
|
KR20140020851A
(ko)
|
2010-12-22 |
2014-02-19 |
마르카디아 바이오테크, 인코퍼레이트 |
Gip 및 glp-1 수용체-활성 글루카곤계 펩타이드를 이용한 대사장애 및 비만의 치료방법
|
EP2492749A1
(en)
|
2011-02-28 |
2012-08-29 |
Rohm and Haas Electronic Materials LLC |
Photoresist compositions and methods of forming photolithographic patterns
|
KR101161526B1
(ko)
|
2011-05-16 |
2012-07-02 |
숭실대학교산학협력단 |
연료전지용 촉매전극을 위한 코어/쉘 구조의 나노 지지체 및 그 제조방법
|
RU2739209C2
(ru)
*
|
2011-06-10 |
2020-12-21 |
Ханми Сайенс Ко., Лтд. |
Новые производные оксинтомодулина и содержащая их фармацевтическая композиция для лечения ожирения
|
DK2721062T3
(en)
|
2011-06-17 |
2019-02-25 |
Hanmi Science Co Ltd |
Conjugate comprising oxyntomodulin and an immunoglobulin fragment as well as its use
|
RU2014101697A
(ru)
|
2011-06-22 |
2015-07-27 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Коагонисты рецепторов глюкагона/glp-1
|
KR101665009B1
(ko)
|
2012-03-09 |
2016-10-11 |
한미사이언스 주식회사 |
비알콜성 지방간 질환의 예방 또는 치료용 약학적 조성물
|
PE20142405A1
(es)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
|
JP6311708B2
(ja)
|
2012-06-21 |
2018-04-18 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
Gip受容体活性を示すグルカゴンアナローグ
|
KR101373563B1
(ko)
|
2012-07-25 |
2014-03-12 |
전북대학교산학협력단 |
Tof-mra를 이용한 혈류특성 및 mr-신호강도구배(전단율) 유도방법
|
KR101968344B1
(ko)
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
WO2014049610A2
(en)
*
|
2012-09-26 |
2014-04-03 |
Cadila Healthcare Limited |
Peptides as gip, glp-1 and glucagon receptors triple-agonist
|
CA2890324C
(en)
|
2012-11-06 |
2021-02-23 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
|
KR101993393B1
(ko)
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
KR20160021758A
(ko)
*
|
2013-04-18 |
2016-02-26 |
노보 노르디스크 에이/에스 |
의학용으로 사용하기 위한 안정하고 연장된 glp-1/글루카곤 수용체 코-아고니스트
|
JP6137046B2
(ja)
|
2014-05-09 |
2017-05-31 |
信越化学工業株式会社 |
単量体、高分子化合物、レジスト材料及びパターン形成方法
|